CD44 and hepatocellular carcinoma: The present study aimed to analyze the expression of CD44, CD90, CD133, and EpCAM in tumor tissue and paired adjacent normal tissue from Thai HCC patients undergoing curative surgical resection who had not previously received therapy to search for associations with clinicopathological characteristics and survival time.